Gov. Gavin Newsom recently signed into law the California Food Safety Act and amendments to the 2020 Toxic-Free Cosmetics Act. Together, they ban four additives commonly used in popular snacks and beverages, and an additional 26 chemicals found in many personal care products.

Read on for details about these developments impacting food and personal care manufacturers, distributors and retailers.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Amy Morrissey Turk Amy Morrissey Turk

Amy is co-chair of the firm’s Consumer Products & Retail industry team. She has significant experience working on complex discrimination matters and wage and hour class actions throughout the country for companies in a variety of industries — most notably the retail industry.

Amy is co-chair of the firm’s Consumer Products & Retail industry team. She has significant experience working on complex discrimination matters and wage and hour class actions throughout the country for companies in a variety of industries — most notably the retail industry. She offers clients a broad spectrum of legal experience gained both as a seasoned litigator for business-focused law firms and also as assistant general counsel in charge of employment legal matters for a multibillion-dollar retail corporation.

Photo of Trent Taylor Trent Taylor

Trent is co-chair of the firm’s Consumer Products & Retail industry team. He focuses on defending complex class actions with an emphasis on product class actions, public and private nuisance litigation, environmental contamination suits, and food, cosmetic, and supplement labeling (including CBD) and…

Trent is co-chair of the firm’s Consumer Products & Retail industry team. He focuses on defending complex class actions with an emphasis on product class actions, public and private nuisance litigation, environmental contamination suits, and food, cosmetic, and supplement labeling (including CBD) and safety issues.

Photo of Allyson Maur Allyson Maur

Allyson advises on regulatory issues affecting diagnostics developers, biopharma manufacturers, and clinical laboratories, including CLIA/CLEP and FDA regulatory advice, MLR and MRC review of marketing and promotional materials, clinical studies, global data privacy issues, ethics & compliance, commercial contracting, commercial litigation and more.

Allyson advises on regulatory issues affecting diagnostics developers, biopharma manufacturers, and clinical laboratories, including CLIA/CLEP and FDA regulatory advice, MLR and MRC review of marketing and promotional materials, clinical studies, global data privacy issues, ethics & compliance, commercial contracting, commercial litigation and more.

Photo of Sophie Mouros Sophie Mouros

Sophie focuses her practice on the healthcare industry, advising her clients on a broad range of healthcare transactional and regulatory matters.

Photo of Royce DuBiner Royce DuBiner

Royce practices food and drug law with a focus on advising pharmaceutical, medical device, cannabis, dietary supplement, tobacco, food and beverage companies as well as investment firms on a range of regulatory matters. He is presently the lead of the Cannabis, Hemp, and…

Royce practices food and drug law with a focus on advising pharmaceutical, medical device, cannabis, dietary supplement, tobacco, food and beverage companies as well as investment firms on a range of regulatory matters. He is presently the lead of the Cannabis, Hemp, and CBD industry team.